State of New Jersey Common Pension Fund D
PensionPosition in SLS — SELLAS Life Sciences Group, Inc.
CIK 1483066
TRENTON, NJ
Position in SLS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$857,068
New position
Shares Held
58,067
first reported quarter
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 192 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of New Jersey Common Pension Fund D holds $245,680,193 across 144 Biotechnology names. SLS ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,245 | $40,853,558 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,596 | $20,948,449 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,883 | $12,909,069 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
52,307 | $9,796,054 | |
| 5 | MRNA |
Moderna, Inc.
|
108,545 | $7,601,406 | |
| 6 | RPRX |
Royalty Pharma plc
|
132,910 | $7,452,263 | |
| 7 | INSM |
INSMED Inc
|
68,049 | $7,255,384 | |
| 8 | INCY |
Incyte Corp
|
54,697 | $6,200,451 |
All Filings in SLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $857,068 | 58,067 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||